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Volume 39, Number 6 Letters to the Editor 1361their case that they could use a side-biting clamp and excise it from
a right thoracotomy.
I do not believe, however, that this approach can be used for
the repair of Kommerell’s diverticula/aneurysms with an associ-
ated aberrant subclavian artery. For this condition we both agree
that a subclavian-carotid transposition followed by a right thora-
cotomy and repair with atriofemoral bypass provides the most
favorable approach.
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Local treatment of Dacron patch graft infected with
biofilm-producing Staphylococcus epidermidis using
antibiotic-releasing porous apatite ceramic: An
experimental study in the rabbit
Some Staphylococcus epidermidis strains produce an extracellu-
lar glycocalyx called biofilm and exhibit a high resistance to anti-
biotics due to this biofilm.1,2,3
We previously reported the efficacy of local treatment with
antibiotics-releasing apatite ceramic (TCP) for prosthetic graft
infection by S aureus.4,5 Usually S aureus does not produce bio-
film. Afterwards, we extended our new treatment method to the
other major prevalent pathogen, biofilm-producing S epidermidis.
S epidermidis, American Type Culture Collection 35984, was
used as the infecting organism. Teicoplanin (TEIC, Aventis
Pharma S A, Germany) was used as the antibiotic. The minimum
inhibitory concentration of TEIC for S epidermidis was 2 mg/mL.
By using the same technique of our previous reports, Dacron
grafts were patched in the anterior wall of the abdominal aorta of
the rabbits. These animals were divided into the following four
groups: (1) the NS group (n  6), a no-treatment group with a
sterile prosthetic vascular graft; (2) the NB group (n  8), a
no-treatment group with a prosthetic vascular graft infected with S
epidermidis; (3) the TA group (n  6), a group with a prosthetic
vascular graft infected with S epidermidis, treated two weeks after
the operation with TEIC (100 mg) locally administered on the
graft; and (4) the TT group (n  6), a group with a prosthetic
vascular graft infected with S epidermidis, treated two weeks after
the operation with TEIC-loaded TCP placed on the infected graft.
The TT group received the same amount of TEIC (100 mg) as the
TA group.
Four weeks after the first operation, all the patched graft was
removed from the abdominal aorta and cultured after its sonica-
tion. Cotton swabs of perigraft fluid and of the graft surface, tissue
around the prosthetic vascular graft, and arterial blood were cul-
tured. In the NS group, no bacteria were recovered by all culturing
methods in all animals. In the NB group, perigraft effusion and
poor graft incorporation were recognized in 5 of 8 (63%) animals.
S epidermidis was recovered in 6 of 8 (75%) animals by sonication.
In the TA group, all animals had normal anastomosis and normal
graft incorporation. S epidermidis was recovered in 5 of 6 (83%)
animals by sonication. In the TT group, all animals had normal
anastomosis, normal graft incorporation, and no perigraft effusion.
S epidermidis was not recovered in any animals. Significant differ-
ences in the infection rate were found between the NB group andTT group (P .01) and between the TA group and the TT group
(P  0.05) (Fig).
We found similar effectiveness against Dacron patch graft
infection with biofilm-producing S epidermidis and efficacy of local
treatment with antibiotics-releasing TCP for prosthetic graft infec-
tion.
Katsuya Shimabukuro, MD
Hajime Hirose, MD, PhD
Yoshio Mori, MD, PhD
Hisato Takagi, MD, PhD
Hisashi Iwata, MD, PhD
Yoshiaki Kawamura, PhD
Gifu University
Gifu, Japan
REFERENCES
1. Bergamini TM, Bandyk DF, Govostis D, Kaebnick HW, Towne JB.
Infection of vascular prostheses caused by bacterial biofilms. J Vasc Surg
1988;7:21-30.
2. D. Mack. Molecular mechanisms of staphylococcus epidermidis biofilm
formation. J Hosp Infect 1999;43(Suppl):113-125.
3. Schwank S, Rajacic Z, Zimmerli W, Blaser J. Impact of bacterial forma-
tion on in vitro and in vivo activities of antibiotics. J Antimicrob Che-
mother 1998;42:895-8.
4. Sago T, Mori Y, Takagi H, Iwata H, Murase K, Kawamura Y. Local
treatment of Dacron patch graft contaminated with Staphylococcus aureus
using antibiotic-releasing porous apatite ceramic: an experimental study
in the rabbit. J Vasc Surg 2003;37:169-74.
5. Murase K, Hirose H, Mori Y, Takagi H, Iwata H, Sago T. Graft-
preserving treatment for vascular graft infected with Staphylococcus aureus
with antibiotic-releasing porous apatite ceramic in the rabbit. J Vasc Surg
2003;38:368-73.
doi:10.1016/j.jvs.2004.03.004
Regarding “Acute arterial complications associated
with total hip and knee arthroplasty”
Dr Calligaro and colleagues reported on acute arterial compli-
cations associated with total hip and knee arthroplasty in the
December issue of JVS (J Vasc Surg 2003;38:1170-7). This is an
important though rare complication of joint replacement, often
with dramatic consequences. In 17 of 18 of their patients with
acute ischemia due to arterial occlusion, surgery to restore blood
flow salvaged the threatened limbs. In one patient, ischemia was
the result of microemboli to the anterior tibial artery branches, and
a fasciotomy was performed. Neither the emboligenic source nor
an intervention to exclude or remove it was reported.
This prompted me to write a description of the significant
consequences of microembolization following a case of total knee
arthroplasty. Beginning a week after knee arthroplasty, episodes of
Recovery of S epidermidis.
